This study evaluates the incidence of symptomatic hyperammonemia (high ammonia levels) in patients being treated with recombinant Erwinia asparaginase.

Hematopoietic and Lymphatic System NeoplasmAcute Lymphobkastic Leukemia

~Estimated

~$10 – $750

Mayo ClinicNCT06600659

Phase 2

Immune Checkpoint Inhibitor Rechallenge in Combination With Siltuximab Prophylaxis for Patients Who Had Prior Immune-Related Adverse Event (CIRES Trial)

This phase II trial studies how well giving siltuximab during the reintroduction (rechallenge) of immune checkpoint inhibitor (ICI) therapy works in preventing…

Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

~Estimated

~$10 – $7,500

Yuanquan YangNCT06470971

← PreviousPage 7 of 7Next →